IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VALENZA, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.191
NA - Nord America 3.446
AS - Asia 3.173
SA - Sud America 291
AF - Africa 69
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.186
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.324
IT - Italia 1.437
SG - Singapore 938
CN - Cina 876
GB - Regno Unito 863
DE - Germania 414
SE - Svezia 346
HK - Hong Kong 280
BD - Bangladesh 261
RU - Federazione Russa 259
BR - Brasile 217
VN - Vietnam 216
FR - Francia 195
IN - India 193
FI - Finlandia 153
NL - Olanda 111
KR - Corea 107
CA - Canada 86
TR - Turchia 86
IE - Irlanda 81
UA - Ucraina 81
JP - Giappone 59
ID - Indonesia 55
DK - Danimarca 47
PL - Polonia 35
EU - Europa 26
ES - Italia 25
CO - Colombia 24
BE - Belgio 21
GR - Grecia 19
CH - Svizzera 18
CI - Costa d'Avorio 18
AR - Argentina 17
MX - Messico 17
NO - Norvegia 17
RO - Romania 14
AU - Australia 13
ZA - Sudafrica 13
PK - Pakistan 12
PH - Filippine 11
IQ - Iraq 10
AT - Austria 9
CZ - Repubblica Ceca 9
PT - Portogallo 9
SA - Arabia Saudita 9
EG - Egitto 8
IR - Iran 8
JO - Giordania 8
EC - Ecuador 7
TN - Tunisia 7
CL - Cile 6
CR - Costa Rica 6
IL - Israele 6
KE - Kenya 6
LU - Lussemburgo 6
MA - Marocco 5
PY - Paraguay 5
RS - Serbia 5
TH - Thailandia 5
TW - Taiwan 5
VE - Venezuela 5
KZ - Kazakistan 4
PE - Perù 4
SC - Seychelles 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
DZ - Algeria 3
LT - Lituania 3
AL - Albania 2
AZ - Azerbaigian 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 11.200
Salva come PNG Salva come JPEG
Città #
Southend 731
Singapore 585
Milan 561
Ashburn 332
Chandler 250
Hong Kong 239
San Jose 230
Dallas 158
Beijing 153
Frankfurt am Main 136
Seattle 126
Fairfield 113
Council Bluffs 111
Los Angeles 109
Wilmington 102
Santa Clara 101
Ann Arbor 96
Helsinki 95
Princeton 93
Dearborn 80
Dublin 80
New York 79
Woodbridge 75
Hefei 66
Ho Chi Minh City 63
Houston 62
Hanoi 57
Seoul 56
Boardman 55
Bengaluru 51
Naples 50
Cambridge 48
Guangzhou 48
Redmond 46
Lauterbourg 44
Rome 44
Buffalo 43
Jacksonville 43
Munich 40
Shanghai 36
Berlin 35
Mountain View 35
Nanjing 35
Jakarta 34
Tokyo 33
Moscow 31
Napoli 31
Turin 31
Des Moines 30
Toronto 28
São Paulo 27
Sakarya 24
Ottawa 23
Phoenix 22
Turku 22
Athens 20
Shenyang 20
Bogotá 19
Abidjan 18
Bologna 18
Redwood City 18
Warsaw 18
Brussels 17
Jinan 17
Sunnyvale 17
Andover 16
Atlanta 16
Columbus 16
Falls Church 16
Somerville 16
Changsha 15
Modena 15
Tianjin 15
Boston 14
Cangzhou 14
London 14
Mumbai 14
Kent 13
Monza 13
Nuremberg 13
San Diego 13
San Francisco 13
Trento 13
Verona 13
Chicago 12
Istanbul 12
Serra 12
The Dalles 12
Washington 12
Wuhan 12
Florence 11
Hebei 11
Padova 11
Pino Torinese 11
Bethesda 10
Brooklyn 10
Dong Ket 10
Fremont 10
Hamburg 10
Hangzhou 10
Totale 6.558
Salva come PNG Salva come JPEG
Nome #
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease 850
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 508
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease 461
Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease 383
Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease 346
Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators 344
Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease : a cross-validation study in Q175 knock-in mice 340
Nanoparticles for transport across the blood-brain barrier 327
Brain-derived neurotrophic factor in patients with Huntington's disease 318
SREBP2 delivery to striatal astrocytes normalizes transcription of cholesterol biosynthesis genes and ameliorates pathological features in Huntington’s Disease 307
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 277
An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin 273
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes 270
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice 261
A gene network regulating lysosomal biogenesis and function 260
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease 260
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery 250
Evaluation of histone deacetylases as drug targets in Huntington's disease models : Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model 250
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 246
Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease 241
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington disease 239
Pitfalls in the detection of cholesterol in Huntington’s disease models 238
Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death 229
Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease 224
A cutting-edge approach based on UHPLC-MS to simultaneously investigate oxysterols and cholesterol precursors in biological samples: Validation in Huntington's disease mouse model 218
Quantitative comparison of the protein corona of nanoparticles with different matrices 214
Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntingtons disease 200
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes 197
The translational potential of cholesterol-based therapies for neurological disease 183
Connection between astrocytes, cholesterol and synaptic dysfunction in Huntington’s disease 183
Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation 173
In vitro and in vivo models of Huntington’s disease show alterations in the endocannabinoid system 173
Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease 165
L16 Identifying a therapeutic regimen for cholesterol delivery to Huntington’s disease brain 165
Cholesterol dysfunction in neurodegenerative diseases : is Huntington's disease in the list? 163
Whole body cholesterol metabolism is impaired in Huntington's disease 161
Cholesterol dysregulation in Rett syndrome: implications for synaptic function 158
Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease 154
Molecular mechanisms and potential therapeutical targets in Huntington's disease 150
Dose-dependent and disease-modifying effects of striatal infusion of cholesterol in Huntington{\textquotesingle}s disease 148
Emerging roles for cholesterol in Huntington's disease 146
Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes 130
Early transcriptional profiles in huntingtin inducible striatal cells by microarray analyses 124
Dysregulated astrocyte cholesterol synthesis in Huntington's disease: A potential intersection with other cellular dysfunctions 112
Neuroprotection and brain cholesterol biosynthesis in Huntington's disease 111
Plasma 24S-OH-cholesterol as a peripheral marker to follow phenoconversion in Huntington’s Disease 110
Pathogenesis 110
Early transcriptional profiles in huntingtin-induced striatal cells by microarray analyses 93
Impairment of lysosomal quality control in Huntington disease 89
Cholesterol dysregulation in Rett syndrome: implications for synaptic function 61
Longitudinal and combined assessment of 24(S)-hydroxycholesterol and Neurofilament light chain in the early stages of Huntington's disease 24
Totale 11.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022777 39 48 41 43 76 46 64 42 77 70 71 160
2022/20231.161 195 141 102 135 124 169 43 52 93 20 48 39
2023/2024771 41 50 87 55 128 45 45 53 40 46 73 108
2024/20251.600 87 141 60 146 119 91 122 179 70 163 128 294
2025/20263.866 284 248 348 276 397 209 535 205 395 240 378 351
2026/202759 59 0 0 0 0 0 0 0 0 0 0 0
Totale 11.617